TAVI pilot outcomes: A South African healthcare funder perspective
Abstract
BACKGROUND: TAVI (Transcatheter aortic valve implantation) is used to replace the aortic valve in the treatment of aortic stenosis in high-risk, elderly patients who are unable to undergo conventional surgical replacement of the aortic valve (SAVR). However, concerns remain regarding the costs, long-term outcomes and safety of the device. A registry was developed by a healthcare funder to assess utilisation, outcomes and cost of this procedure in their patient population. METHODS: Registry data was collected for a period of 17 months. Clinical entry criteria included high-risk, elderly patients with symptomatic, severe aortic valve
disease who were unsuitable for surgical valve replacement. Clinical outcomes were mortality, readmission and pacemaker requirements post-surgery. Primary outcome measure was all-cause mortality at 30 days.
RESULTS: A cohort of 78 patients was enrolled, mean age of 79.53 years. Procedures were performed in 7 centers around the country. Thirty day all-cause mortality was 9 (11.54%) with 5 deaths occurring on the day of the procedure. Eighteen (23.1%) patients were readmitted within 30 days. Average LOS was 5.71 (±4.06SD) days with an average cost of ZAR327 962 per patient. CONCLUSION: Results suggest outcomes are similar to
other settings and countries. Ongoing data collection is required to better understand long-term outcomes and costs.
disease who were unsuitable for surgical valve replacement. Clinical outcomes were mortality, readmission and pacemaker requirements post-surgery. Primary outcome measure was all-cause mortality at 30 days.
RESULTS: A cohort of 78 patients was enrolled, mean age of 79.53 years. Procedures were performed in 7 centers around the country. Thirty day all-cause mortality was 9 (11.54%) with 5 deaths occurring on the day of the procedure. Eighteen (23.1%) patients were readmitted within 30 days. Average LOS was 5.71 (±4.06SD) days with an average cost of ZAR327 962 per patient. CONCLUSION: Results suggest outcomes are similar to
other settings and countries. Ongoing data collection is required to better understand long-term outcomes and costs.
Full Text:
PDFDOI: https://doi.org/10.24170/11-3-1751
Refbacks
- There are currently no refbacks.
ISSN: 2071-4602 (online) ISSN: 1996-6741 (print)
Copyright © 2017 SA Heart Journal
Hosted by Stellenbosch University Library and Information Service since 2017.
Creative Commons License -CC BY-NC-ND 4.0
Disclaimer:
This journal is hosted by the SU LIS on request of the journal owner/editor. The SU LIS takes no responsibility for the content published within this journal, and disclaim all liability arising out of the use of or inability to use the information contained herein. We assume no responsibility, and shall not be liable for any breaches of agreement with other publishers/hosts.